Albumins: egg albumin, not dried

In 2024, albumins: egg albumin, not dried trade exhibited significant decline, with global flows reaching $104,634,348 and a three-year compound annual growth rate of +5.8% (five-year: +9.2%). The all-time peak of $148,917,385 was recorded in 2022; the current level is 30% below that high-water mark.

Over the 30-year observation window (1995–2024), 66% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is strengthening (+3.0% acceleration).

The World Trade Flows Characterization classifies albumins: egg albumin, not dried as "One-way trade" in the high price range price segment, providing additional context for market positioning and competitive dynamics.

The supply side is diversified (Herfindahl-Hirschman Index 0.113). The three largest exporters — Netherlands ($22.8M), France ($16.5M), and Italy ($10.5M) — collectively dominate supply flows. The leading exporter has grown at +5.2% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.072). The three largest import markets are Italy ($16.4M), United Kingdom ($14.7M), and Ireland ($7.2M). The largest importing market sources from 11 different supplying countries.

Estimated substitution elasticity: -2.86. Buyers have moderate flexibility to shift sourcing, but face some switching costs.

The dominant trade corridor is France → Italy at $8.6M, representing 52.4% of the importer's total demand.

The volatility score for albumins: egg albumin, not dried is 14 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.